HealthDay - TUESDAY, Oct. 11 (HealthDay News) -- Women who have the BRCA2 gene mutation that raises the risk for both breast and ovarian cancer are more likely to survive ovarian cancer than other women, a new study indicates.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.